Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health
- PMID: 31780306
- DOI: 10.1016/S2215-0366(19)30298-6
Pharmacoepidemiology research: delivering evidence about drug safety and effectiveness in mental health
Abstract
Research that provides an evidence base for the pharmacotherapy of people with mental disorders is needed. The abundance of digital data has facilitated pharmacoepidemiology and, in particular, observational research on the effectiveness of real-world medication. Advantages of pharmacoepidemiological research are the availability of large patient samples, and coverage of under-researched subpopulations in their naturalistic conditions. Such research is also cheaper and quicker to do than randomised controlled trials, meaning that issues regarding generic medication, stopping medication (deprescribing), and long-term outcomes are more likely to be addressed. Pharmacoepidemiological methods can also be extended to pharmacovigilance and to aid the development of new purposes for existing drugs. Drawbacks of observational pharmacoepidemiological studies come from the non-randomised nature of treatment selection, leading to confounding by indication. Potential methods for managing this drawback include active comparison groups, within-individual designs, and propensity scoring. Many of the more rigorous pharmacoepidemiology studies have been strengthened through multiple analytical approaches triangulated to improve confidence in inferred causal relationships. With developments in data resources and analytical techniques, it is encouraging that guidelines are beginning to include evidence from robust observational pharmacoepidemiological studies alongside randomised controlled trials. Collaboration between guideline writers and researchers involved in pharmacoepidemiology could help researchers to answer the questions that are important to policy makers and ensure that results are integrated into the evidence base. Further development of statistical and data science techniques, alongside public engagement and capacity building (data resources and researcher base), will be necessary to take full advantage of future opportunities.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.Therapie. 2019 Apr;74(2):279-288. doi: 10.1016/j.therap.2018.09.076. Epub 2019 Jan 31. Therapie. 2019. PMID: 30824175
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Interest of pharmacoepidemiology for the study of psychotropic drugs.Therapie. 2019 Apr;74(2):239-244. doi: 10.1016/j.therap.2019.01.007. Epub 2019 Feb 2. Therapie. 2019. PMID: 30792080
-
Study designs in paediatric pharmacoepidemiology.Eur J Clin Pharmacol. 2011 May;67 Suppl 1:67-74. doi: 10.1007/s00228-010-0930-2. Epub 2010 Nov 25. Eur J Clin Pharmacol. 2011. PMID: 21107830 Review.
Cited by
-
What gets recorded, counts: dementia recording in primary care compared with a specialist database.Age Ageing. 2021 Nov 10;50(6):2206-2213. doi: 10.1093/ageing/afab164. Age Ageing. 2021. PMID: 34417796 Free PMC article.
-
Prediction of treatment dosage and duration from free-text prescriptions: an application to ADHD medications in the Swedish prescribed drug register.Evid Based Ment Health. 2021 Nov;24(4):146-152. doi: 10.1136/ebmental-2020-300231. Epub 2021 Apr 1. Evid Based Ment Health. 2021. PMID: 33795353 Free PMC article.
-
Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness.Front Psychiatry. 2021 Apr 12;12:643609. doi: 10.3389/fpsyt.2021.643609. eCollection 2021. Front Psychiatry. 2021. PMID: 33912086 Free PMC article.
-
Aspirin in people with dementia, long-term benefits, and harms: a systematic review.Eur J Clin Pharmacol. 2021 Jul;77(7):943-954. doi: 10.1007/s00228-021-03089-x. Epub 2021 Jan 22. Eur J Clin Pharmacol. 2021. PMID: 33483830 Free PMC article.
-
So near yet so far: why won't the UK prescribe medical cannabis?BMJ Open. 2020 Sep 21;10(9):e038687. doi: 10.1136/bmjopen-2020-038687. BMJ Open. 2020. PMID: 32958492 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical